AgenciesUS stock market Gilead Sciences Inc (GILD) stocks, Expedia Group Inc (EXPE) share price on Friday skyrocketed. Gilead Sciences jumped 8.8 per cent for one of the biggest gains. It reported financial results that easily beat analysts' forecasts, while also raising its earnings forecast for the year. Expedia Group also notched one of the biggest gains, advancing 4.4 per cent after also reporting encouraging financial results. Gilead Sciences Inc and Expedia Group Inc are among the final big batch of companies within the S&P 500 to report mostly strong financial results for the second quarter. Still, many have warned that current tariffs could cut into their profits and operations.Stocks rose in morning trading on Wall Street Friday, keeping the market on track for its third weekly gain in the last four. The S&P 500 was up 0.7 per cent and sitting just below its record. The benchmark index is on track to wipe out its losses from a slide last week. Dow Jones Industrial Average rose 212 points, or 0.5 per cent. The Nasdaq added 0.8 per cent to the all-time high it set a day earlier. Technology companies, with their hefty stock values, were doing much of the heavy lifting for the market. Nvidia rose 0.9 per cent and Microsoft rose 0.2 per cent.Productivity ToolZero to Hero in Microsoft Excel: Complete Excel guideBy Metla Sudha SekharFinanceIntroduction to Technical Analysis & Candlestick TheoryBy Dinesh NagpalFinanceFinancial Literacy i e Lets Crack the Billionaire CodeBy CA Rahul GuptaDigital MarketingDigital Marketing Masterclass by Neil PatelBy Neil PatelFinanceTechnical Analysis Demystified- A Complete Guide to TradingBy Kunal PatelProductivity ToolExcel Essentials to Expert: Your Complete GuideBy Study at homeArtificial IntelligenceAI For Business Professionals Batch 2By Ansh MehraGilead Sciences Inc (GILD) Gilead Sciences Inc. is a leading U.S.-based biopharmaceutical company headquartered in Foster City, California, specializing in antiviral and oncology drugs. Known for major treatments in HIV/AIDS, hepatitis, COVID-19, and cancer, the company is a significant member of the Nasdaq‑100, S&P 100, and S&P 500 indices.Gilead has since raised its full-year earnings guidance to $7.95–$8.25 per share and product revenue outlook to $28.3–$28.7 billion. Analysts are bullish: Morgan Stanley increased its price target to $143, while TD Cowen raised theirs to $115.Live EventsExpedia GroupExpedia Group, Inc., a marquee player in online travel services, operates a diverse portfolio including Expedia.com, Hotels.com, Vrbo, Travelocity, and more. As of August 8, 2025, the stock trades around $193, following a strong Q2 earnings beat that sent shares soaring in pre- and after-hours trading. Analyst reactions are mixed but generally bullish. J.P. Morgan lifted its target to $225 (Neutral); Melius bumped theirs to $210 (Buy); Evercore ISI set a high of $280 (Outperform).FAQsQ1. How are Gilead Sciences Inc stocks performing?A1. Gilead Sciences jumped 8.8 per cent for one of the biggest gains. It reported financial results that easily beat analysts' forecasts, while also raising its earnings forecast for the year.Q2. How are Expedia Group stocks performing?A2. Expedia Group also notched one of the biggest gains, advancing 4.4 per cent after also reporting encouraging financial results.(You can now subscribe to our Economic Times WhatsApp channel) Read More News onUS stock marketUS stock market todayGilead Sciences IncGILDExpedia GroupEXPE (Catch all the US News, UK News, Canada News, International Breaking News Events, and Latest News Updates on The Economic Times.) Download The Economic Times News App to get Daily International News Updates....moreless (You can now subscribe to our Economic Times WhatsApp channel)Read More News onUS stock marketUS stock market todayGilead Sciences IncGILDExpedia GroupEXPE(Catch all the US News, UK News, Canada News, International Breaking News Events, and Latest News Updates on The Economic Times.) Download The Economic Times News App to get Daily International News Updates....moreless Explore More Stories123